Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP486986.RAIokYOf6CTp-ojlU9ElJgaeB7i4XtW64ukqbhB5W-vUU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP486986.RAIokYOf6CTp-ojlU9ElJgaeB7i4XtW64ukqbhB5W-vUU130_assertion type Assertion NP486986.RAIokYOf6CTp-ojlU9ElJgaeB7i4XtW64ukqbhB5W-vUU130_head.
- NP486986.RAIokYOf6CTp-ojlU9ElJgaeB7i4XtW64ukqbhB5W-vUU130_assertion description "[We have recently identified an EGFR mutation E884K, in combination with L858R, in a patient with advanced lung cancer who progressed on erlotinib maintenance therapy, and subsequently had leptomeningeal metastases that responded to gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP486986.RAIokYOf6CTp-ojlU9ElJgaeB7i4XtW64ukqbhB5W-vUU130_provenance.
- NP486986.RAIokYOf6CTp-ojlU9ElJgaeB7i4XtW64ukqbhB5W-vUU130_assertion evidence source_evidence_literature NP486986.RAIokYOf6CTp-ojlU9ElJgaeB7i4XtW64ukqbhB5W-vUU130_provenance.
- NP486986.RAIokYOf6CTp-ojlU9ElJgaeB7i4XtW64ukqbhB5W-vUU130_assertion SIO_000772 19015641 NP486986.RAIokYOf6CTp-ojlU9ElJgaeB7i4XtW64ukqbhB5W-vUU130_provenance.
- NP486986.RAIokYOf6CTp-ojlU9ElJgaeB7i4XtW64ukqbhB5W-vUU130_assertion wasDerivedFrom befree-20140225 NP486986.RAIokYOf6CTp-ojlU9ElJgaeB7i4XtW64ukqbhB5W-vUU130_provenance.
- NP486986.RAIokYOf6CTp-ojlU9ElJgaeB7i4XtW64ukqbhB5W-vUU130_assertion wasGeneratedBy ECO_0000203 NP486986.RAIokYOf6CTp-ojlU9ElJgaeB7i4XtW64ukqbhB5W-vUU130_provenance.